Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 06, 2016 8:52 AM ET

Health Care Technology

Company Overview of PatientsLikeMe, Inc.

Company Overview

PatientsLikeMe, Inc. operates an online health data and information sharing Website for patients. It enables patients to share data with other patients, caregivers, physicians, researchers, and pharmaceutical and medical device companies. The company offers data and information on patients, treatments, symptoms, and research. Its data and information helps researchers learn how diseases act in the real world and accelerate the discovery of new treatments. PatientsLikeMe, Inc. was founded in 2004 and is based in Cambridge, Massachusetts.

155 Second Street

Cambridge, MA 02141

United States

Founded in 2004



Key Executives for PatientsLikeMe, Inc.

Chief Executive Officer
Age: 50
Co-Founder, President and Director
Co-Founder and Chairman
Chief Financial Officer
Age: 60
Chief Operating Officer
Age: 42
Compensation as of Fiscal Year 2015.

PatientsLikeMe, Inc. Key Developments

PatientsLikeMe, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 01:00 PM

PatientsLikeMe, Inc. Presents at Boston Biotech East West CEO Conference, Jan-10-2016 01:00 PM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Dan Poscover.

The American College of Cardiology and PatientsLikeMe Launch Partnership to Bring Patient Focus to Diabetes Research and Care

The American College of Cardiology (ACC) and PatientsLikeMe launched a partnership to explore innovative ways to make real-world patient feedback and experience more central to diabetes research and care. Focused on the ACC’s Diabetes Collaborative Registry, the partnership will encourage people living with diabetes to offer perspectives to enhance and accelerate the registry’s research and development agenda. The announcement was made during American Diabetes Month and at the start of the week marking the International Diabetes Federation’s World Diabetes Day. The Diabetes Collaborative Registry is the first global, cross-specialty clinical diabetes registry designed to track and improve the quality of diabetes and cardiometabolic care delivered to patients across the primary and specialty care continuum. The registry’s founding industry sponsor, AstraZeneca, is also a PatientsLikeMe partner and shares the goal to bring the patient voice into the center of scientific discovery and development. The collaboration’s first step calls for the ACC and PatientsLikeMe to reach out to people living with diabetes to identify priorities for the registry’s research and program development agenda. Practices participating in the Diabetes Collaborative Registry will be able to offer their patients access to the PatientsLikeMe website so they can become part of the online patient community, which is open to any patient living with diabetes. Nearly 20,000 people already use the website to connect in forums and to track and share their experiences living with diabetes, including reporting the severity of symptoms such as fatigue, pain and depressed mood, quality of life, and the effectiveness of various treatments or non-drug interventions.

PatientsLikeMe and the FDA Sign Research Collaboration Agreement

PatientsLikeMe and the U.S. Food and Drug Administration (FDA) have signed a research collaboration agreement to determine how patient-reported data can give new insights into drug safety. Under the collaboration, PatientsLikeMe and the FDA will systematically explore the potential of patient-generated data to inform regulatory review activities related to risk assessment and risk management. The cornerstone of the FDA’s post-approval drug safety surveillance is a spontaneous reporting system consisting of individual case safety reports. Reporting adverse events to the FDA is mandatory for drug product manufacturers but voluntary for healthcare professionals and patients. The majority of these individual case safety reports are submitted by healthcare professionals and patients to drug product manufacturers, who then have regulatory requirements to report them to the FDA. The PatientsLikeMe data are generated in a different context by patients themselves, and provide important real-time insights into the nuances inherent in patients’ experiences over time, including drug tolerance, adherence and quality of life.

Similar Private Companies By Industry

Company Name Region
Niemi Group United States
Nalari Health, LLC United States
MDnetSolutions, LLC United States
Enterprise Systems Software, LLC United States
Viatronix Incorporated United States

Recent Private Companies Transactions

Private Placement
May 7, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PatientsLikeMe, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at